Senate Targets Chinese Biotech, Investments in Defense Bill

The US Senate backed legislation that would bar certain Chinese biotech companies from receiving federal funding and prohibit American investments in sensitive Chinese industries late Thursday night.

Both bipartisan measures were added to the National Defense Authorization Act on voice votes, reflecting widespread support. The House and Senate must agree on identical bills and have them signed by President Donald Trump for them to become law.

Yet even with the Senate vote, it’s not certain the provision will ultimately become law. For example, last year’s version of the Biosecure Act was omitted from the final Defense policy bill amid concerns ...